As WTO members eye expanding TRIPS decision, U.S. treads carefully

As lawmakers and industry groups increase pressure against the push at the World Trade Organization to expand a recent intellectual property decision to include diagnostics and therapeutics, the Biden administration has kept a low profile, declining to say publicly where it stands -- but its past positions and a recent statement suggest no eagerness to move forward on the issue. WTO members during the 12th ministerial conference last month agreed to further flexibilities under the Agreement on Trade-Related Aspects of...